Evidence map›Paper›PMID 29849176›Full record

ArticleScientific reports2018

Common genetic variation in the autoimmune regulator (AIRE) locus is associated with autoimmune Addison's disease in Sweden.

Daniel Eriksson, Matteo Bianchi, Nils Landegren, Frida Dalin, Jakob Skov, Lina Hultin-Rosenberg, Argyri Mathioudaki, Jessika Nordin, Åsa Hallgren, Göran Andersson and 13 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Aire Mutations and Autoimmune Diseases.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Article
  5. International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Adrenal insufficiency.Nature reviews. Disease primers · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Association BetweenIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Daniel ErikssonDepartment of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden. daniel.eriksson@ki.se.ORCID 0000-0001-5473-3312
Matteo BianchiScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Nils LandegrenDepartment of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Frida DalinDepartment of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Jakob SkovDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Lina Hultin-RosenbergScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Argyri MathioudakiScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Jessika NordinScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Åsa HallgrenDepartment of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Göran AnderssonDepartment of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Karolina TandreScience for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Solbritt Rantapää DahlqvistDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Peter SöderkvistDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0001-9867-8706
Lars RönnblomScience for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Anna-Lena HultingDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jeanette WahlbergDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Per DahlqvistDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Olov EkwallDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jennifer R S MeadowsScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Kerstin Lindblad-TohScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Sophie BensingDepartment of Endocrinology, Metabolism and Diabetes Karolinska University Hospital, Stockholm, Sweden.
Gerli Rosengren PielbergScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Olle KämpeDepartment of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6091-9914
Uppsala University · SEKarolinska Institutet · SEKarolinska University Hospital · SELinköping University · SEUmeå University · SEBroad Institute · USSwedish University of Agricultural Sciences · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune Addison's disease (AAD) is the predominating cause of primary adrenal failure. Despite its high heritability, the rarity of disease has long made candidate-gene studies the only feasible methodology for genetic studies. Here we conducted a comprehensive reinvestigation of suggested AAD risk loci and more than 1800 candidate genes with associated regulatory elements in 479 patients with AAD and 2394 controls. Our analysis enabled us to replicate many risk variants, but several other previously suggested risk variants failed confirmation. By exploring the full set of 1800 candidate genes, we further identified common variation in the autoimmune regulator (AIRE) as a novel risk locus associated to sporadic AAD in our study. Our findings not only confirm that multiple loci are associated with disease risk, but also show to what extent the multiple risk loci jointly associate to AAD. In total, risk loci discovered to date only explain about 7% of variance in liability to AAD in our study population.

Indexed as

Genetic VariationAddison DiseaseAIRE ProteinBasic-Leucine Zipper Transcription FactorsCTLA-4 AntigenGenetic LociGenetic Predisposition to DiseaseGenomicsHaplotypesHumansLectins, C-TypeMonosaccharide Transport ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 22SwedenTranscription FactorsAIRE ProteinBACH2 protein, humanBasic-Leucine Zipper Transcription FactorsCLEC16A protein, humanCTLA-4 AntigenCTLA4 protein, humanLectins, C-TypeMonosaccharide Transport ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanTranscription Factors

Identifiers

PMID29849176
PMCPMC5976627
OpenAlexW2806994180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.